Impact of Regulatory Delays in Drug Approval: Mortality and Morbidity Due to With Lack of Access to Crizotinib in Brazil
Pablo Moura Barrios, Marcio Debiasi, Gilberto Lopes, Carlos H. BarriosOctober 2016 Volume 11, Issue 10, Supplement, Page S215 Full link: https://www.jto.org/article/S1556-0864(16)30782-1/fulltext